|
Volumn 24, Issue 6, 1992, Pages 3047-3048
|
Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BESTATIN;
ACUTE NONLYMPHOCYTIC LEUKEMIA;
ADOLESCENT;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CHILD;
CHRONIC MYELOID LEUKEMIA;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG EFFECT;
EARLY DIAGNOSIS;
FEMALE;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNOPOTENTIATION;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
BONE MARROW TRANSPLANTATION;
CHILD;
CHILD, PRESCHOOL;
CHRONIC DISEASE;
FEMALE;
GRAFT VS HOST DISEASE;
GRAFT VS HOST REACTION;
HUMAN;
INFANT;
LEUCINE;
LEUKEMIA, MYELOID, CHRONIC;
LEUKEMIA, NONLYMPHOCYTIC, ACUTE;
MALE;
RECURRENCE;
|
EID: 0027096943
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (8)
|
References (0)
|